Quality of life in multiple sclerosis: determinants, measurement, and use in clinical practice.

Current Neurology and Neuroscience Reports
D Miller, Rebecca Allen

Abstract

Multiple sclerosis (MS) is a complex demyelinating disease with a relatively unpredictable course. It is well established that MS has a significant impact on health-related quality of life (HRQL) for individuals at all stages of the disease. It is argued that clinicians offer treatment to their patients for three reasons: 1) to increase longevity, 2) to prevent future morbidity, and 3) to make patients feel better. To assess how well they are accomplishing the third of these goals, clinicians have come to depend on the direct measurement of patients' HRQL. We review the many physical and emotional symptoms and other consequences of MS that negatively influence HRQL, how HRQL is measured, the unique information these measures provide compared with clinical parameters, the benefit of treatment interventions, and how to include HRQL assessment and data from other sources in clinical encounters and suggest measures to consider for clinical use.

References

Oct 1, 1985·ANS. Advances in Nursing Science·C E Ferrans, M J Powers
Jun 1, 1995·Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation·B G VickreyG W Ellison
Apr 1, 1996·Archives of Physical Medicine and Rehabilitation·C E SchwartzP Retzlaff
Jun 1, 1996·Journal of Neurology·G J LankhorstL Vleugels
Sep 1, 1999·Multiple Sclerosis : Clinical and Laboratory Research·J S FischerD Paty
Feb 24, 2001·International Journal for Quality in Health Care : Journal of the International Society for Quality in Health Care·Z RotsteinA Achiron
May 4, 2001·Brain : a Journal of Neurology·J HobartA Thompson
Mar 6, 2003·Multiple Sclerosis : Clinical and Laboratory Research·M W Nortvedt, T Riise
Nov 11, 2003·Journal of the Neurological Sciences·Robert ZivadinovGiuseppe Cazzato
Nov 18, 2003·Disability and Rehabilitation·Julián Benito-LeónAlex Mitchell
Aug 4, 2004·Quality & Safety in Health Care·J E Epping-JordanE H Wagner
Mar 22, 2005·Pain·Kristina Bacher SvendsenFlemming Winther Bach
Dec 8, 2005·The Journal of Alternative and Complementary Medicine : Research on Paradigm, Practice, and Policy·Edward H WagnerMichael Vonkorff
Feb 8, 2006·Multiple Sclerosis : Clinical and Laboratory Research·S L MindenD C Hoaglin
Jul 19, 2006·Journal of Rehabilitation Research and Development·Joseph B GuarnacciaJohn Booss
Feb 1, 2007·Multiple Sclerosis : Clinical and Laboratory Research·O LilyH Ford
Feb 14, 2007·Multiple Sclerosis : Clinical and Laboratory Research·M W NortvedtK M Myhr
Apr 19, 2007·Multiple Sclerosis : Clinical and Laboratory Research·A G BeiskeUNKNOWN Nordic SPMS study group
Apr 20, 2007·The Cochrane Database of Systematic Reviews·F KhanT Kilpatrick
Jun 15, 2007·Scandinavian Journal of Caring Sciences·Satu HeiskanenAnna-Maija Pietilä
Aug 19, 2007·Annals of Neurology·Richard A RudickUNKNOWN AFFIRM and SENTINEL Investigators
Sep 21, 2007·Multiple Sclerosis : Clinical and Laboratory Research·R W Motl, J L Gosney
Oct 3, 2007·Mayo Clinic Proceedings·Marlene H FrostUNKNOWN Clinical Significance Consensus Meeting Group
Oct 3, 2007·Mayo Clinic Proceedings·Gordon H GuyattUNKNOWN Clinical Significance Consensus Meeting Group
Oct 19, 2007·Multiple Sclerosis : Clinical and Laboratory Research·Mc SimeoniUNKNOWN MusiQol study group
Jan 5, 2008·Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation·J M ValderasJ Alonso
Jan 19, 2008·Journal of Neurology, Neurosurgery, and Psychiatry·F KhanT Kilpatrick
May 10, 2008·International Journal of Rehabilitation Research. Internationale Zeitschrift Für Rehabilitationsforschung. Revue Internationale De Recherches De Réadaptation·Prem ChopraGenevieve Kennedy
Oct 28, 2008·Disability and Rehabilitation·K WyniaS A Reijneveld
Nov 19, 2008·Health and Quality of Life Outcomes·Olympia HadjimichaelUNKNOWN North American Research Committee on Multiple Sclerosis
Dec 2, 2008·The British Journal of Clinical Psychology·Louise H PhillipsMaggie Whyte
Jan 21, 2009·Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology·Benedetta GorettiMaria Pia Amato
Feb 10, 2009·Journal of the Neurological Sciences·Tjalf Ziemssen
Feb 26, 2009·Journal of Neurology, Neurosurgery, and Psychiatry·E M MowryL J Balcer
May 16, 2009·Journal of Neurology·Katherine TreadawayElliot M Frohman

❮ Previous
Next ❯

Citations

Nov 6, 2012·The Journal of Neuroscience Nursing : Journal of the American Association of Neuroscience Nurses·Pamela K NewlandArleen Fearing
Jun 30, 2012·European Journal of Neurology : the Official Journal of the European Federation of Neurological Societies·J Benito-LeónJ M Morales-González
Aug 25, 2012·Multiple Sclerosis : Clinical and Laboratory Research·Robert J FoxKim Zuidwijk
May 9, 2014·Medical Science Monitor : International Medical Journal of Experimental and Clinical Research·Alessandro ClemenziMaria Grazia Grasso
Sep 12, 2013·International Journal of Medical Informatics·Lisa A OsborneJ Gareth Noble
Dec 12, 2012·European Journal of Neurology : the Official Journal of the European Federation of Neurological Societies·A GiordanoUNKNOWN POSMOS study
Apr 23, 2015·Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology·Lorena LoreficeM G Carta
Feb 27, 2015·Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation·Rosalba RosatoAntonio Bertolotto
May 27, 2015·Multiple Sclerosis and Related Disorders·Rana KarabudakBassem I Yamout
May 27, 2015·Multiple Sclerosis and Related Disorders·Peter RieckmannPatrick Vermersch
Dec 24, 2013·Epilepsy & Behavior : E&B·David VictorsonDavid Cella
Aug 26, 2014·Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation·Karon F CookDeborah Miller
Mar 17, 2015·Lancet Neurology·Anthony FeinsteinAlbert C Lo
Sep 16, 2017·Neurotherapeutics : the Journal of the American Society for Experimental NeuroTherapeutics·Cindy J NowinskiDavid Cella
Aug 19, 2017·Multiple Sclerosis : Clinical and Laboratory Research·Dayo AfolabiKlaus Schmierer
Mar 27, 2018·New Directions for Student Leadership·Lindsay J Hastings, Cindy Kane
Aug 10, 2012·Palliative & Supportive Care·Jacoba J M Jansen van RensburgCorrien van Belkum
Apr 7, 2011·Nature Reviews. Neurology·Bernd C Kieseier, Olaf Stüve
Nov 12, 2019·Brain and Behavior·Tamás BiernackiKrisztina Bencsik
May 6, 2019·Advances in Therapy·Jane K RhodesRichard A Rudick
Feb 20, 2013·The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques·Marcelo Kremenchutzky, Len Walt
Apr 13, 2011·Current Opinion in Neurology·Bernd C KieseierOlaf Stüve
Nov 11, 2019·Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation·Andrea GiordanoRosalba Rosato
Feb 1, 2011·Acupuncture in Medicine : Journal of the British Medical Acupuncture Society·Jens Foell
Feb 16, 2021·Multiple Sclerosis and Related Disorders·Cássia Elisa MarinUNKNOWN Brazilian Committee for Treatment and Research in Multiple Sclerosis (BCTRIMS)
Mar 22, 2021·Archives of public health = Archives belges de santé publique·Laurenske A VisserWilliam K Redekop

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.